Pfizer Announces Positive Top-Line Results For Potential Biosimilar To Rituxan®/MabThera®

Go back to Pfizer Announces Positive Top-Line Results For Potential Biosimilar To Rituxan®/MabThera®
Pfizer Inc. (NYSE: PFE) Delayed: 24.72 -0.36 (1.44%)
Previous Close $25.08    52 Week High $37.39 
Open $24.99    52 Week Low $28.25 
Day High $25.24    P/E 14.98 
Day Low $24.69    EPS $1.65 
Volume 81,994,445